批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/10/16 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/28 |
SUPPL-40(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2022/09/30 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/05/19 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/10/14 |
SUPPL-39(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2021/09/15 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/11/16 |
SUPPL-38(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2020/11/16 |
SUPPL-36(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2019/06/11 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/01/09 |
SUPPL-32(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2018/11/11 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/11/03 |
SUPPL-30(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2017/03/24 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/11/02 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2016/07/18 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2016/06/10 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/07/09 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/08/29 |
SUPPL-20(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2014/08/29 |
SUPPL-19(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2014/08/12 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/01/16 |
SUPPL-15(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2013/10/02 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/09/25 |
SUPPL-9(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2013/09/25 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/04/17 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/08 |
SUPPL-5(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2013/02/05 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/08/10 |
SUPPL-13(补充) |
Approval |
REMS |
N/A
|
|
|
2010/04/20 |
SUPPL-3(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/11/18 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/10/28 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:LACOSAMIDE 剂型/给药途径:SOLUTION;INTRAVENOUS 规格:200MG/20ML (10MG/ML) 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
218464 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
--
|
ACELLA |
022254 |
001 |
NDA |
VIMPAT |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
Yes |
Yes |
AP |
2008/10/28
|
UCB INC |
214301 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/04/07
|
INDOCO |
214677 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/05/03
|
FRESENIUS KABI USA |
209465 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/06/29
|
ZYDUS PHARMS |
216335 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/09/14
|
ASPIRO |
215628 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/09/19
|
GLAND PHARMA LTD |
215979 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2023/02/09
|
MSN |
216670 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2023/11/13
|
APOTEX |
217311 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/02/13
|
HAINAN POLY |
217718 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/03/25
|
DR REDDYS |
216806 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/04/05
|
HIKMA |
214960 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/10/09
|
SOMERSET THERAPS LLC |